Litcius/Paper detail

Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study

Vahan Képénékian, Julien Péron, Benoît You, Isabelle Bonnefoy, Laurent Villeneuve, Mohammad Alyami, Naoual Bakrin, Pascal Rousset, Nazim Benzerdjeb, Olivier Gléhen

2021Annals of Surgical Oncology23 citationsDOI

Topics & Concepts

MedicineCytoreductive surgerySurgical oncologyPeritoneal mesotheliomaChemotherapyIntraperitoneal chemotherapyMesotheliomaHyperthermic intraperitoneal chemotherapySurgeryCohortOncologyInternal medicinePathologyCancerOvarian cancerIntraperitoneal and Appendiceal MalignanciesOccupational and environmental lung diseasesNanoparticle-Based Drug Delivery
Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study | Litcius